David Hasdai
Overview
Explore the profile of David Hasdai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
9911
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yerushalmi E, Abu T, Hasdai D, Aviv Y, Kornowski R, Skalsky K
Cardiology
. 2025 Jan;
:1-7.
PMID: 39761656
Introduction: Lung transplantation (LT) is a lifesaving procedure in patients with end stage lung failure. The prevalence of coronary artery disease (CAD) in patients with lung disease is comparably high,...
2.
3.
Maqsood M, Levine G, Kleiman N, Hasdai D, Uretsky B, Birnbaum Y
J Clin Med
. 2023 Dec;
12(24).
PMID: 38137601
Aspirin has for some time been used as a first-line treatment for acute coronary syndromes, including ST-elevation myocardial infarction, for secondary prevention of established coronary disease, and for primary prevention...
4.
Cohen B, Tor R, Grossman A, Kornowski R, Porter A, Hasdai D
J Clin Med
. 2023 Sep;
12(17).
PMID: 37685771
(1) Background: patients who meet current rapid rule-out criteria for myocardial infarction (MI) are considered low risk, yet their management remains nebulous, especially among women. We aimed to examine sex...
5.
Cohen B, Cohen S, Tor R, Shochat T, Fuchs S, Kornowski R, et al.
Eur Heart J Qual Care Clin Outcomes
. 2023 Jan;
9(3):207-215.
PMID: 36694945
Aims: Many patients with suspected non-ST-elevation (NSTE) acute coronary syndromes (ACS) are admitted, even those with initial high-sensitivity cardiac troponins (hs-cTn) values who meet rapid rule-out criteria for myocardial infarction...
6.
Abu T, Levi A, Hasdai D, Kramer M, Bental T, Bdolah-Abram T, et al.
BMC Cardiovasc Disord
. 2022 Jul;
22(1):324.
PMID: 35858878
No abstract available.
7.
Abu T, Levi A, Hasdai D, Kramer M, Bental T, Bdolah-Abram T, et al.
BMC Cardiovasc Disord
. 2022 Feb;
22(1):53.
PMID: 35172724
Background: Right heart catheterization (RHC) and echocardiography are both routinely used for pulmonary artery systolic pressure (PASP) assessment in lung transplantation (LT) candidates, although this is not mandated by current...
8.
Eliaz R, Mengesha B, Ovdat T, Iakobishvili Z, Hasdai D, Kheifets M, et al.
Cardiology
. 2021 Nov;
147(2):113-120.
PMID: 34808635
Introduction: We aimed to compare the outcomes of acute coronary syndrome (ACS) patients undergoing in-hospital percutaneous coronary intervention treated with prasugrel versus ticagrelor. Methods: Among 7,233 patients enrolled to the...
9.
Itzhaki Ben Zadok O, Murninkas D, Iakobishvili Z, Jino H, Yohananov E, Birkenfeld S, et al.
Isr Med Assoc J
. 2020 Nov;
22(7):441-445.
PMID: 33236570
Background: Heart failure (HF) patients with reduced ejection fraction (HFrEF) are frequently treated with sub-optimal doses of angiotensin converting enzyme-inhibitors (ACE-Is), angiotensin receptor blockers (ARBs), and beta blockers (BBs). Objectives:...
10.
Birnbaum Y, Levine G, French J, Kaski J, Atar D, Alam M, et al.
Cardiovasc Drugs Ther
. 2020 Jul;
34(6):865-870.
PMID: 32671603
The pivotal studies that led to the recommendations for emergent reperfusion therapy for ST-elevation myocardial infarction (STEMI) were conducted for the most part over 25 years ago. At that time,...